Romiplostim: an alternative treatment option besides rituximab for the management of steroid refractory idiopathic thrombocytopenic purpura

Shailendra Kapoor

首页> 外文期刊>Journal of Thrombosis and Thrombolysis >Romiplostim: an alternative treatment option besides rituximab for the management of steroid refractory idiopathic thrombocytopenic purpura

【24h】

Romiplostim: an alternative treatment option besides rituximab for the management of steroid refractory idiopathic thrombocytopenic purpura

机译：Romiplostim：除了利妥昔单抗以外的另一种治疗方案，用于治疗类固醇难治性特发性血小板减少性紫癜

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Thrombosis and Thrombolysis》 |2009年第4期|p.1-1|共1页
作者
Shailendra Kapoor;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Romiplostim: an alternative treatment option besides rituximab for the management of steroid refractory idiopathic thrombocytopenic purpura. [J] . Kapoor S Journal of thrombosis and thrombolysis . 2009,第4期

机译：Romiplostim：除了利妥昔单抗外，还可以治疗类固醇难治性特发性血小板减少性紫癜。
2. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults [J] . Kayoko Kikuchi, Yoshitaka Miyakawa, Shunya Ikeda, BMC Health Services Research . 2015,第1期

机译：在脾切除术和romiplostim中添加利妥昔单抗治疗成人类固醇耐药性特发性血小板减少性紫癜的成本效益
3. Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab [J] . Mohanad Ahmed, Mohamed A. Yassin, Elabbass Abdelmahmuod Cureus. . 2020,第9期

机译：类固醇难治性慢性特发性血小板细胞发作性血小伤症对Eltompopag和Rituximab的组合治疗
4. Platelet count control in immune thrombocytopenic purpura patient: optimum romiplostim dose profile [C] . Chia-Hung Tsai, James Bussel, Allison Imahiyerobo, IFAC World Congress . 2014

机译：免疫血小板减少紫癜患者血小板计数控制：最佳的romiplosim剂量曲线
5. The risk of idiopathic thrombocytopenic purpura (ITP) following measles, mumps, and rubella (MMR) vaccination: Attributable risk and a simulation study to evaluate four study designs. [D] . Glanz, Jason M. 2005

机译：麻疹，腮腺炎和风疹（MMR）疫苗接种后特发性血小板减少性紫癜（ITP）的风险：可归因的风险和模拟研究，以评估四种研究设计。
6. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults [O] . Kayoko Kikuchi, Yoshitaka Miyakawa, Shunya Ikeda, 2015

机译：在脾切除术和romiplostim中添加利妥昔单抗治疗成人类固醇耐药性特发性血小板减少性紫癜的成本效益
7. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults [O] . Kayoko Kikuchi, Yoshitaka Miyakawa, Shunya Ikeda, 2015

机译：在脾切除术和romiplostim中添加利妥昔单抗治疗成人类固醇耐药性特发性血小板减少性紫癜的成本效益

Romiplostim: an alternative treatment option besides rituximab for the management of steroid refractory idiopathic thrombocytopenic purpura

著录项

相似文献

相关主题

期刊订阅